Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma.

Bordoloi D, Monisha J, Roy NK, Padmavathi G, Banik K, Harsha C, Wang H, Kumar AP, Arfuso F, Kunnumakkara AB.

Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3437-3446. doi: 10.31557/APJCP.2019.20.11.3437.

2.

Concise review: Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells.

Visweswaran M, Arfuso F, Warrier S, Dharmarajan A.

Stem Cells. 2019 Oct 24. doi: 10.1002/stem.3101. [Epub ahead of print]

PMID:
31648395
3.

Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice.

Mooranian A, Zamani N, Takechi R, Al-Sallami H, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H.

Ther Deliv. 2019 Oct 24. doi: 10.4155/tde-2019-0052. [Epub ahead of print]

PMID:
31646943
4.

Bioactive lipids in cancer stem cells.

Begicevic RR, Arfuso F, Falasca M.

World J Stem Cells. 2019 Sep 26;11(9):693-704. doi: 10.4252/wjsc.v11.i9.693. Review.

5.

Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model.

Mooranian A, Zamani N, Luna G, Al-Sallami H, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Kovacevic B, Al-Salami H.

Pharm Dev Technol. 2019 Dec;24(10):1272-1277. doi: 10.1080/10837450.2019.1665069. Epub 2019 Sep 26.

PMID:
31557068
6.

Anti-cancer effects of oxymatrine are mediated through multiple molecular mechanism(s) in tumor models.

Halim CE, Xinjing SL, Fan L, Bailey Vitarbo J, Arfuso F, Tan CH, Narula AS, Kumar AP, Sethi G, Ahn KS.

Pharmacol Res. 2019 Sep;147:104327. doi: 10.1016/j.phrs.2019.104327. Epub 2019 Jul 5. Review.

PMID:
31283981
7.

Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma.

Roy NK, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar NS, Singh AK, Bordoloi D, Baruah MN, Ahmed GN, Longkumar I, Arfuso F, Kumar AP, Kunnumakkara AB.

Biomolecules. 2019 Jun 27;9(7). pii: E253. doi: 10.3390/biom9070253.

8.

Focus on Formononetin: Anticancer Potential and Molecular Targets.

Ong SKL, Shanmugam MK, Fan L, Fraser SE, Arfuso F, Ahn KS, Sethi G, Bishayee A.

Cancers (Basel). 2019 May 1;11(5). pii: E611. doi: 10.3390/cancers11050611. Review.

9.

Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets.

Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB.

Pharmacol Res. 2019 Jun;144:192-209. doi: 10.1016/j.phrs.2019.04.004. Epub 2019 Apr 17. Review.

PMID:
31002949
10.

An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques.

Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Elnashar M, Arfuso F, Al-Salami H.

PLoS One. 2019 Apr 4;14(4):e0214984. doi: 10.1371/journal.pone.0214984. eCollection 2019.

11.

Role of Natural Products in Modulating Histone Deacetylases in Cancer.

Merarchi M, Sethi G, Shanmugam MK, Fan L, Arfuso F, Ahn KS.

Molecules. 2019 Mar 16;24(6). pii: E1047. doi: 10.3390/molecules24061047. Review.

12.

Potential of Zerumbone as an Anti-Cancer Agent.

Girisa S, Shabnam B, Monisha J, Fan L, Halim CE, Arfuso F, Ahn KS, Sethi G, Kunnumakkara AB.

Molecules. 2019 Feb 18;24(4). pii: E734. doi: 10.3390/molecules24040734. Review.

13.

Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.

Mandal S, Arfuso F, Sethi G, Dharmarajan A, Warrier S.

Int J Biochem Cell Biol. 2019 May;110:59-69. doi: 10.1016/j.biocel.2019.02.001. Epub 2019 Feb 6.

PMID:
30735730
14.

Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment.

Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H.

Ther Deliv. 2019 Feb;10(2):99-106. doi: 10.4155/tde-2018-0034.

PMID:
30729887
15.

Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.

Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A.

Int J Biochem Cell Biol. 2019 Apr;109:23-32. doi: 10.1016/j.biocel.2019.01.016. Epub 2019 Jan 30.

PMID:
30710752
16.

The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.

Ma Z, Wang YY, Xin HW, Wang L, Arfuso F, Dharmarajan A, Kumar AP, Wang H, Tang FR, Warrier S, Tergaonkar V, Sethi G.

Int J Biochem Cell Biol. 2019 Mar;108:17-20. doi: 10.1016/j.biocel.2019.01.003. Epub 2019 Jan 7. Review.

PMID:
30630112
17.

Stemness, Pluripotentiality, and Wnt Antagonism: sFRP4, a Wnt antagonist Mediates Pluripotency and Stemness in Glioblastoma.

Bhuvanalakshmi G, Gamit N, Patil M, Arfuso F, Sethi G, Dharmarajan A, Kumar AP, Warrier S.

Cancers (Basel). 2018 Dec 27;11(1). pii: E25. doi: 10.3390/cancers11010025.

18.

Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis.

Shanmugam MK, Ahn KS, Hsu A, Woo CC, Yuan Y, Tan KHB, Chinnathambi A, Alahmadi TA, Alharbi SA, Koh APF, Arfuso F, Huang RY, Lim LHK, Sethi G, Kumar AP.

Front Pharmacol. 2018 Dec 4;9:1294. doi: 10.3389/fphar.2018.01294. eCollection 2018.

19.

Pharmacological Utilization of Bergamottin, Derived from Grapefruits, in Cancer Prevention and Therapy.

Ko JH, Arfuso F, Sethi G, Ahn KS.

Int J Mol Sci. 2018 Dec 14;19(12). pii: E4048. doi: 10.3390/ijms19124048. Review.

20.

Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes.

Regan SLP, Knight PG, Yovich JL, Arfuso F, Dharmarajan A.

Fertil Steril. 2018 Dec;110(7):1298-1310. doi: 10.1016/j.fertnstert.2018.08.018.

PMID:
30503129

Supplemental Content

Loading ...
Support Center